Efficacy of Desmopressin and Enuresis Alarm as First and Second Line Treatment for Primary Monosymptomatic Nocturnal Enuresis: Prospective Randomized Crossover Study
Authors:
- 1 December 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 184 (6) , 2521-2526
Abstract
We compared the efficacy of desmopressin and enuresis alarm as first and second line treatment options for monosymptomatic nocturnal enuresis. A total of 104 children with monosymptomatic nocturnal enuresis were randomly assigned to either desmopressin (54) or enuresis alarm (50) as first line treatment. Following 12 weeks of first line treatment children with a full response were evaluated for relapse 12 weeks after withdrawal of treatment. Children with partial or no response were switched to the alternative treatment and then evaluated after 12 weeks of crossover treatment. Relapse was defined as more than 1 episode of bedwetting monthly. Following first line treatment 77.8% of the desmopressin group and 82% of the enuresis alarm group achieved a successful result, including full response in 37% and 50% of the groups, respectively (p=0.433). Of the children with a full response 50% in the desmopressin group and 12% in the enuresis alarm group experienced a relapse when treatment stopped (p=0.005). Following second line crossover treatment 71.4% of the enuresis alarm-desmopressin group and 67.8% of the desmopressin-enuresis alarm group achieved a successful result, including full response in 47.6% and 45.2% of the groups, respectively (p=0.961). There was no difference between desmopressin and enuresis alarm during treatment for achieving dryness, but the chance of relapse after treatment stopped was higher following desmopressin. Switching to the alternative treatment following partial or no response provided an additional benefit.Keywords
This publication has 24 references indexed in Scilit:
- Evaluation of different modes of combined therapy in children with monosymptomatic nocturnal enuresisBJU International, 2010
- Structured Desmopressin Withdrawal Improves Response and Treatment Outcome for Monosymptomatic Enuretic ChildrenJournal of Urology, 2009
- Characteristics of a Tertiary Center Enuresis Population, With Special Emphasis on the Relation Among Nocturnal Diuresis, Functional Bladder Capacity and Desmopressin ResponseJournal of Urology, 2007
- The Standardization of Terminology of Lower Urinary Tract Function in Children and Adolescents: Report from the Standardisation Committee of the International Children’s Continence SocietyJournal of Urology, 2006
- Desmopressin for nocturnal enuresis in childrenCochrane Database of Systematic Reviews, 2002
- EXAMINATION OF THE STRUCTURED WITHDRAWAL PROGRAM TO PREVENT RELAPSE OF NOCTURNAL ENURESISJournal of Urology, 2001
- EFFICACY OF DESMOPRESSIN COMBINED WITH ALARM THERAPY FOR MONOSYMPTOMATIC NOCTURNAL ENURESISJournal of Urology, 2001
- THE EFFICACY AND SAFETY OF ORAL DESMOPRESSIN IN CHILDREN WITH PRIMARY NOCTURNAL ENURESISJournal of Urology, 2001
- Long‐term treatment with desmopressin in children with primary monosymptomatic nocturnal enuresis: an open multicentre studyBritish Journal of Urology, 1998
- CHANGES IN NOCTURNAL BLADDER CAPACITY DURING TREATMENT WITH THE BELL AND PAD FOR MONOSYMPTOMATIC NOCTURNAL ENURESISJournal of Urology, 1998